Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Dec 3;105(12):1591–1600. doi: 10.1111/cas.12556

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Fig. 6 — The 5y-RFS of patients with combination both EGFR and HER3 expression, as detected using IHC, was analyzed using Kaplan Meier survival curves. (a) The 5y-RFS of combination both EGFR and HER3 overexpression was 44.4%, and indicated poor prognosis (P = 0.0003). (b) The 5y-RFS of combination both EGFR and HER3 overexpression was 74.3% in pStage II. (c) The 5y-RFS of combination both EGFR and HER3 overexpression was 34.5% and indicated poor prognosis comparing other combinations in pStage IIIA. (d) The 5y-RFS of combination both EGFR and HER3 overexpression was 25.0% and indicated poor prognosis comparing other combinations in pStage IIIB.